With great fanfare and misleading statements, on August 23, 2021, the FDA granted conditional approval pending further testing for a German vaccine which is generally unavailable (the BioNTech vaccine, which is supposedly similar to the Pfizer vaccine in ingredients), while extending the EUA authorization (not approval) of the Pfizer vaccine. By combining the two decisions in one announcement, the FDA mislead the public to think that the Pfizer vaccine had been approved. It has not been. | With great fanfare and misleading statements, on August 23, 2021, the FDA granted conditional approval pending further testing for a German vaccine which is generally unavailable (the BioNTech vaccine, which is supposedly similar to the Pfizer vaccine in ingredients), while extending the EUA authorization (not approval) of the Pfizer vaccine. By combining the two decisions in one announcement, the FDA mislead the public to think that the Pfizer vaccine had been approved. It has not been. |